Fortress Biotech, Inc.FBIOEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 9.00% | 2.7M | — | 2024-10-25 |
| of Above Person | 8.90% | 180.4K | ▼ -0.90pp | 2024-11-15 |
| Nantahala | 4.20% | 372.6K | — | 2024-02-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-01 | David Jin | Chief Financial Officer | Grant | 3.0K | $2.18 | $6.5K |
| 2026-03-18 | WEISS MICHAEL S | Executive Vice Chairman | Grant | 475.4K | $0.00 | $0 |
| 2026-03-18 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Grant | 475.4K | $0.00 | $0 |
1–3 of 3